The Introduction of a HuR-Binding Site in the 3' UTR and the CD47 Cytoplasmic Tail Enhances SARS-CoV-2 S-Protein Expression in Cells. [PDF]
Pereverzev IM +4 more
europepmc +1 more source
MYC promotes the progression of prostate cancer by regulating CD47 to induce an immunosuppressive microenvironment. [PDF]
Xin S +14 more
europepmc +1 more source
Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation. [PDF]
Kang X, Yang X, Wu H, Tong X, Wang S.
europepmc +1 more source
If Plan A Does Not Work: The CD47 Ectodomain as a Target for Immune Tolerance. [PDF]
Montero E, Isenberg JS.
europepmc +1 more source
Designing universal T cell therapies: strategies to evade natural killer cells. [PDF]
Bushara O, Linette GP, Carreno BM.
europepmc +1 more source
Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting. [PDF]
Su Y +5 more
europepmc +1 more source
Low-dose DOX-polygodial nanosystem modulates the CD47/CALR axis for safer triple negative breast cancer treatment. [PDF]
Emara HM +4 more
europepmc +1 more source
The Role of Mesothelin in Gynecological Tumors and Its Significance in Targeted Therapies-A Review. [PDF]
Kawecka W +5 more
europepmc +1 more source
CD24 as an innate immune checkpoint in solid tumors: biology, biomarker stratification, and therapeutic translation. [PDF]
Zhou W, Huang X, Jia G, Lu C, Ma W.
europepmc +1 more source

